Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-10-26 | "Mr. Schimmelpennink has close to 25 years of biotech and pharmaceutical experience... Mr. Schimmelpennink earned a M.Sc. in bioprocess engineering from the University of Wageningen in the Netherlands and a Business Degree from the Arnhem Business School." |
| 2022-05-24 | Evert Schimmelpennink(10) ... Includes 99,695 shares of Common Stock underlying stock options that are fully vested. |
| 2022-10-26 | "Mr. Schimmelpennink has close to 25 years of biotech and pharmaceutical experience ... Mr. Schimmelpennink earned a M.Sc. in bioprocess engineering" |
| 2023-10-26 | "Mr. Schimmelpennink earned a M.Sc. in bioprocess engineering from the University of Wageningen in the Netherlands and a Business Degree from the Arnhem Business School." |
| 2024-10-10 | "Mr. Schimmelpennink has close to 25 years of biotech and pharmaceutical experience... Mr. Schimmelpennink earned a M.Sc. in bioprocess engineering..." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-26